ORIGINAL RESEARCH article
Front. Med.
Sec. Intensive Care Medicine and Anesthesiology
This article is part of the Research TopicThe Role of Advanced Statistical Techniques in Infectious Disease ResearchView all 6 articles
Group-Based Trajectory Modeling of Platelet Dynamics in Sepsis: From phenotypic identification to the exploration of prognostic mediators
Provisionally accepted- 1Jiangsu University, Zhenjiang, China
- 2Zhenjiang First People's Hospital, Zhenjiang, China
- 3Danyang People's Hospital of Jiangsu Province, Danyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Sepsis continues to impose a substantial global burden, with persistently high rates of hospitalization and mortality. A major challenge in advancing sepsis therapeutics lies in its inherent clinical and biological heterogeneity. Recent research has increasingly shifted from static biomarker assessment toward the identification of dynamic trajectory subtypes to better capture this heterogeneity. Objective: This study aims to characterize the temporal patterns of platelet count changes during the first three days after admission among 280 sepsis patients using group-based trajectory modeling (GBTM), assess their association with clinical outcomes, and explore potential mediating pathways. Methods: We retrospectively analyzed data from 280 sepsis patients between September 2022 and December 2024. Baseline demographics, clinical characteristics, and serial platelet counts were collected. Missing data were addressed using multiple imputation techniques. GBTM was applied to identify distinct trajectory patterns of platelet counts. The association between each trajectory and 28-day all-cause mortality was evaluated using multivariable Cox proportional hazards regression models. Additionally, mediation analysis was performed to investigate potential mechanisms underlying these associations. Results: GBTM revealed three distinct platelet count trajectories: persistent low level (71.79%), high-level decline (20.00%), and rebound rise (8.21%). Patients in the persistent low-level group exhibited significantly higher 28-day all-cause mortality compared to the other two groups (71.63% vs. 55.36% vs. 13.04%, p < 0.05) and had the shortest median survival time. After adjusting for key confounders, Cox regression showed that, relative to the persistent low-level group, the high-level decline group had a 42% lower risk of death (HR = 0.58, 95% CI: 0.36–0.92, p = 0.02), while the rebound rise group demonstrated an 93% reduction in mortality risk (HR = 0.07, 95% CI: 0.02–0.26, p < 0.001). Mediation analysis indicated that the effect of platelet trajectories on 28-day mortality may be partially mediated through changes in Sequential Organ Failure Assessment (SOFA) score and log-transformed APTT. Conclusion: Dynamic modeling of platelet count trajectories enables effective identification of clinically meaningful subphenotypes in sepsis patients, offering a robust framework for prognosis prediction. This approach supports refined risk stratification and personalized management strategies, thereby providing novel insights into the pathophysiology and clinical care of sepsis.
Keywords: Group-based trajectory modeling, phenotype, Platelet, Sepsis, SOFA (Sequential (Sepsis-related) Organ Failure Assessment)
Received: 05 Dec 2025; Accepted: 05 Feb 2026.
Copyright: © 2026 Zhang, Cai, Ni, Ma, Yang and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hongfeng Yang
Fang Ye
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
